ES8103972A1 - Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina - Google Patents
Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrinaInfo
- Publication number
- ES8103972A1 ES8103972A1 ES490848A ES490848A ES8103972A1 ES 8103972 A1 ES8103972 A1 ES 8103972A1 ES 490848 A ES490848 A ES 490848A ES 490848 A ES490848 A ES 490848A ES 8103972 A1 ES8103972 A1 ES 8103972A1
- Authority
- ES
- Spain
- Prior art keywords
- bencyclane fumarate
- preparation
- bencyclane
- fumarate
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nanotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biotechnology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
PROCEDIMIENTO PARA PREPARAR UNA COMPOSICION FARMACEUTICA QUE CONTIENE FUMARATO DE BENCICLANO Y CICLODEXTRINA. SE OBTIENE MEZCLANDO FUMARATO DE BENCICLANO Y CICLODEXTRINA EN UNA RELACION MOLAR DE 1:5 Y 5:1, CON LO CUAL SE CONVIERTE TODO O PARTE EN UN COMPUESTO DE INCLUSION. LA MEZCLA SE LLEVA A CABO AMASANDO LOS COMPONENTES DURANTE 0,1-12 HORAS, JUNTO CON AGUA O UNA MEZCLA DE AGUA O UNO O MAS DISOLVENTES ORGANICOS MISCIBLES CON AGUA. LA MEZCLA RESULTANTE SE SECA MEDIANTE LIOFILIZACION, SECADO POR PULVERIZACION O AL VACIO. LOS DISOLVENTES ORGANICOS EMPLEADOS PUEDEN SER METANOL, ETANOL, ACETONA, ALCOHOL N-PROPILO O ALCOHOL ISOPROPILICO.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5216479A JPS55143911A (en) | 1979-04-26 | 1979-04-26 | Bencyclane fumarate preparation |
JP15715179A JPS5679650A (en) | 1979-12-04 | 1979-12-04 | Bencyclane fumarate clathrate compound |
JP920180A JPS55143912A (en) | 1980-01-28 | 1980-01-28 | Useful preparation comprising bencyclane fumarate |
JP1704280A JPS56113712A (en) | 1980-02-13 | 1980-02-13 | Production of pharmaceutical preparation of bencyclane fumarate |
Publications (2)
Publication Number | Publication Date |
---|---|
ES490848A0 ES490848A0 (es) | 1981-04-16 |
ES8103972A1 true ES8103972A1 (es) | 1981-04-16 |
Family
ID=27455119
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES490848A Expired ES8103972A1 (es) | 1979-04-26 | 1980-04-24 | Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina |
Country Status (7)
Country | Link |
---|---|
US (1) | US4352793A (es) |
EP (1) | EP0018773B1 (es) |
CA (1) | CA1146545A (es) |
DE (1) | DE3063842D1 (es) |
ES (1) | ES8103972A1 (es) |
HU (1) | HU183129B (es) |
MX (1) | MX5999E (es) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5830032B2 (ja) * | 1981-02-18 | 1983-06-27 | 呉羽化学工業株式会社 | ビフイダス菌の増殖剤 |
HU183430B (en) * | 1981-05-12 | 1984-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing cyclodextrine inclusion complexes of n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine or n-bracket-1-phenylethyl-bracket closed-3,3-diphenylpropylamine-hydrochloride |
DE3372705D1 (en) * | 1982-04-30 | 1987-09-03 | Takeda Chemical Industries Ltd | Pharmaceutical composition and its use |
JPS6140298A (ja) * | 1984-06-30 | 1986-02-26 | Zeria Shinyaku Kogyo Kk | シクロアルテノ−ルフエルラ酸エステル−シクロデキストリン複合体 |
US5002935A (en) * | 1987-12-30 | 1991-03-26 | University Of Florida | Improvements in redox systems for brain-targeted drug delivery |
US5017566A (en) * | 1987-12-30 | 1991-05-21 | University Of Florida | Redox systems for brain-targeted drug delivery |
US5007966A (en) * | 1988-09-21 | 1991-04-16 | American Maize-Products Company | Cyclodextrin complexing method |
US5997856A (en) * | 1988-10-05 | 1999-12-07 | Chiron Corporation | Method and compositions for solubilization and stabilization of polypeptides, especially proteins |
US5602112A (en) * | 1992-06-19 | 1997-02-11 | Supergen, Inc. | Pharmaceutical formulation |
US20040014695A1 (en) * | 1992-06-19 | 2004-01-22 | Supergen, Inc. | Pharmaceutical formulation |
US5824668A (en) * | 1996-11-07 | 1998-10-20 | Supergen, Inc. | Formulation for administration of steroid compounds |
US5942501A (en) * | 1996-08-16 | 1999-08-24 | Collaborative Laboratories, Inc. | Cyclodextrin derivative complex |
US20070009532A1 (en) * | 2005-07-06 | 2007-01-11 | Branimir Sikic | Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar |
US20070010487A1 (en) * | 2005-07-06 | 2007-01-11 | Jeff Schwegman | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
US20070010485A1 (en) * | 2005-07-06 | 2007-01-11 | Jeff Schwegman | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
US20070010478A1 (en) * | 2005-07-06 | 2007-01-11 | Branimir Sikic | Zosuquidar, daunorubicin, and cytarabine for the treatment of cancer |
US20070010486A1 (en) * | 2005-07-06 | 2007-01-11 | Jeff Schwegman | Chemotherapeutic formulations of zosuquidar trihydrochloride and modified cyclodextrins |
US10532102B2 (en) | 2016-08-19 | 2020-01-14 | Foresee Pharmaceuticals Co., Ltd. | Pharmaceutical composition and methods of uses |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE895769C (de) * | 1951-08-26 | 1953-11-05 | Knoll Ag | Verfahren zur Herstellung von Einschlussverbindungen physiologisch wirksamer organischer Verbindungen |
HU179141B (es) * | 1977-09-23 | 1982-08-28 | ||
HU176215B (en) * | 1978-01-27 | 1981-01-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing a cyclodextrin-indomethacin inclusion complex with a ratio of at about 2:1 |
-
1980
- 1980-04-08 US US06/138,562 patent/US4352793A/en not_active Expired - Lifetime
- 1980-04-10 CA CA000349526A patent/CA1146545A/en not_active Expired
- 1980-04-23 EP EP80301315A patent/EP0018773B1/en not_active Expired
- 1980-04-23 DE DE8080301315T patent/DE3063842D1/de not_active Expired
- 1980-04-24 MX MX808774U patent/MX5999E/es unknown
- 1980-04-24 ES ES490848A patent/ES8103972A1/es not_active Expired
- 1980-04-25 HU HU801038A patent/HU183129B/hu not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
US4352793A (en) | 1982-10-05 |
ES490848A0 (es) | 1981-04-16 |
EP0018773B1 (en) | 1983-06-22 |
EP0018773A1 (en) | 1980-11-12 |
DE3063842D1 (en) | 1983-07-28 |
MX5999E (es) | 1984-09-18 |
HU183129B (en) | 1984-04-28 |
CA1146545A (en) | 1983-05-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8103972A1 (es) | Un procedimiento para preparar una composicion farmaceutica que contiene fumarato de benciclano y ciclodextrina | |
HU171717B (hu) | Sposob poluchenija slozhnykh alkil'nykh ehfirov 1,4-digidropiridin-karbonovoj kisloty i lechebnykh preparatov soderzhahhikh takie soedinenija | |
PH21386A (en) | Platinum-diamine complexes, their pharmaceutical compositions and process for the preparation thereof | |
HU173557B (hu) | Sposob poluchenija 3-amino-indazol-karbonovojj kisloty i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami | |
DE3061586D1 (en) | Pancreozymin-cholezystokinin active peptides, process for their preparation and pharmaceutical compositions containing them | |
AU496764B2 (en) | new 2, 3-DIHYDRO-1-BENZOTHIEPIN-4-CARBOXAMIDES PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
HU175439B (hu) | Insekticidnye kompozicii soderzhahhie proizvodnye n-skobka-3-triflorometil-4-galogeno-fenil-skobka zakryta-n-zapjataja vverkh-benzoil-mocheviny i sposob poluchenija aktivnogo agenta | |
GB1544647A (en) | 2-piperidinoalkyl-1-benzofurans-1,4-benzodioxans and 1,4-benzoxathians process for their manufacture and pharmaceutical preparations containing them | |
DE2966179D1 (en) | Pyridyl- and imidazopyridyloxypropanolamines, process for preparing the same and pharmaceutical compositions containing the same | |
JPS5297926A (en) | Process for preparing pharmaceutically active compound* its composition and therapeutical method by utilization thereof | |
HU175157B (hu) | Sposob poluchenija 0,s-dialkil-0-fenil-tiofenil-fosfotiolatnykh proizvodnykh i pesticidnye preparaty soderzhashchie takie soedinenija kak aktivnye veshchestva | |
HU174981B (hu) | Sposob poluchenija n-skobka-1-allil-2-pirrolidilmetil-skobka zakryta-2,3-dimetoksi-5-sul'famoil-benzamida i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami | |
DE3064773D1 (en) | Novel quinazoline derivatives, a pharmaceutical composition containing such derivatives as active ingredient and a process for producing the quinazoline derivatives | |
AU540216B2 (en) | Nicotinamide derivative, process for preparing the same and pharmaceutical composition containing the same | |
IL49463A (en) | Compositions containing a mineral hypophosphite as active ingredient,for controlling fungus disease in plants and method using such compositions | |
DE2961524D1 (en) | Glycofuranosyl-nitrosourea derivatives, process for their manufacture and their pharmaceutical preparations | |
EG12274A (en) | Process for the preparation of anthelmintic preparations containing 4(4-nitroanilino)-phenylisothiocyanate | |
HU174882B (hu) | Sposob poluchenija proizvodnykh 1,12-metanooksimetano-indolo-kvadratnaja skobka-2,3-a-kvadratnaja skobka zakryta-kinolizina i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami | |
HU171992B (hu) | Insekticidnye, akaricidnye i nematocidnye kompozicija soderzhahhie slozhnye efiry i efiramidy 0-triazolil-skobka-tiono-skobka zakryta-fosfornojj-, skobka-fosfonnojj-ili fosfinnojj-skobka zakryta-kislot, i sposob poluchenija aktivnykh agentov | |
JPS51131847A (en) | Process for preparation of 2,2'- dithiobisbenzamide compounds | |
NL7511662A (nl) | Werkwijze ter bereiding van 1-gesubstitueerde deri- vaten van 6'n-methyl-3'-4'-dideoxykanamycine b, alsmede farmaceutische preparaten die deze verbin- dingen als actieve component bevatten. | |
ES8601694A1 (es) | Procedimiento para preparar un compuesto de inclusion a base de n,n-dimetil-2-cloro-5(3-metil-2-(fenilimino)-4-tiazolin-4-il)-fenilsulfonamida y b-ciclodextrina | |
CA1027561A (en) | Pharmacologically active 1,4-benzodiazepins and process for their preparation | |
CA953715A (en) | N(6)-(2,5-dimethylbenzyl)-2-chloroadenosine derivatives, process for their preparation and pharmaceutical compositions containing the same | |
HU174754B (hu) | Sposob poluchenija proizvodnykh 1,3-digidro-spiro-skobka-izobenzofuran-1,4-piperidina-skobka zakryta i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami |